BUNKER KEVIN D. (Chief Operating Officer) sold 4.8% of their position (10K shares) of ZENTALIS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $792.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 12/21/2021ACC: 0001725160-21-000244
Officer· Chief Operating Officer
Since Apr 2020
-10K
Net shares
Net seller
$792.4K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
10K disposed
Non-Derivative Transactions4
Common Stock
Indirect
Shares
−2.16K
Price / share
$77.45
Trade value
$167.37K
% of position
1.0%
12/20/2021
210K→207.84K
Common Stock
Indirect
Shares
−1.88K
Price / share
$78.52
Trade value
$147.54K
% of position
0.9%
12/20/2021
207.84K→205.96K
Common Stock
Indirect
Shares
−3.89K
Price / share
$79.78
Trade value
$310.27K
% of position
1.9%
12/20/2021
205.96K→202.07K
Common Stock
Indirect
Shares
−2.07K
Price / share
$80.76
Trade value
$167.25K
% of position
1.0%
12/20/2021
202.07K→200K
Total
Net shares
−10K
Net value
-$792.43K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 12/20/2021 | S · Sale | −2.16K | $77.45 | $167.37K | 1.0% | 210K | 207.84K |
| Common Stock Indirect | 12/20/2021 | S · Sale | −1.88K | $78.52 | $147.54K | 0.9% | 207.84K | 205.96K |
| Common Stock Indirect | 12/20/2021 | S · Sale | −3.89K | $79.78 | $310.27K | 1.9% | 205.96K | 202.07K |
| Common Stock Indirect | 12/20/2021 | S · Sale | −2.07K | $80.76 | $167.25K | 1.0% | 202.07K | 200K |
| Total | −10K | -$792.43K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned350.00
Common Stock
DirectShares owned755.07K
Total
755.07K direct·350.00 indirect755.42K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 350.00 | Indirect |
| Common Stock | 755.07K | Direct |
| Total | 755.42K | 755.07K direct·350.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported